(Q38435854)

3 September 2017

Non-uptake of highly active antiretroviral therapy among patients with a CD4 count < 350 cells/μL in the UK. (English)

1 reference

3 September 2017

anti-retroviral agent

0 references

J Anderson

5

0 references

Caroline Sabin

19

object named as

C A Sabin

1 reference

3 September 2017

C Kober

1

1 reference

3 September 2017

M Johnson

2

1 reference

3 September 2017

M Fisher

3

1 reference

3 September 2017

T Hill

4

1 reference

3 September 2017

L Bansi

6

1 reference

3 September 2017

M Gompels

7

1 reference

3 September 2017

A Palfreeman

8

1 reference

3 September 2017

D Dunn

9

1 reference

3 September 2017

B Gazzard

10

1 reference

3 September 2017

R Gilson

11

1 reference

3 September 2017

F Post

12

1 reference

3 September 2017

A N Phillips

13

1 reference

3 September 2017

J Walsh

14

1 reference

3 September 2017

C Orkin

15

1 reference

3 September 2017

V Delpech

16

1 reference

3 September 2017

J Ainsworth

17

1 reference

3 September 2017

C Leen

18

1 reference

3 September 2017

UK Collaborative HIV Cohort (CHIC) Study

20

1 reference

3 September 2017

22 November 2011

1 reference

3 September 2017

1 reference

3 September 2017

13

1 reference

3 September 2017

73-78

1 reference

3 September 2017

1

1 reference

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).

3 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2006).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

British HIV Association (BHIVA) national cohort outcomes audit of patients commencing antiretrovirals from naïve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

Newly diagnosed HIV infections: review in UK and Ireland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

HIV transmission and high rates of late diagnoses among adults aged 50 years and over

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

The therapeutic implications of timely linkage and early retention in HIV care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

The creation of a large UK-based multicentre cohort of HIV-infected individuals: The UK Collaborative HIV Cohort (UK CHIC) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

CD4 cell count and initiation of antiretroviral therapy: trends in seven UK centres, 1997?2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2011.00956.X

10.1111/J.1468-1293.2011.00956.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference